The Afternoon Update with Lynlee Foo
About
Stay in the know with programs such as Viewpoint and Industry Insights in property, cryptocurrency, aviation, and shipping. We delve into the latest news, current events, and market updates to provide you with valuable insights into making informed financial decisions.
JAN 25, 2022
25/01/22 - Market View, 25 JanOn Market View, Claressa Monteiro is joined by Sani Hamid, Director for Wealth Management, Financial Alliance, as they deep dive into MAS's latest announcement to 'raise slightly' rate of appreciation of policy band to counter rising inflation, the reason behind Asian shares taking a tumble today, what to look out for upcoming flash PMIs this week, the Reits sector, revenge buying and investor sentiments.
|
|
|
16:53
|
JAN 24, 2022
24/01/22 - Market View, 24 JanOn Market View, Claressa Monteiro is joined by Geoff Howie, Market Strategist at the SGX as they break down the numbers of the just released CPI of Singapore, the STI, the trio of local banks' performance, Reits's earning reports, who's leading the markets in the region as well as the key focus of the Federal Open Market Committee meeting this week.
|
|
|
18:24
|
JAN 21, 2022
21/01/22 - Inspect A Gadget: Unusual SmartwatchesOn Inspect A Gadget, Claressa Monteirois joined by Christopher Lim, Digital Editor, The Business Times, as they look at some of the unusual smartwatches for different needs.
|
|
|
17:56
|
JAN 21, 2022
21/01/22 - Market View Wrap, 21 JanOn Market View, Claressa Monteiro is joined by Geoff Howie, Market Strategist at the SGX as they review the week's market movements - namely SPACs Vertex and Pegasus kicked off their trading on the SGX, factors on why the STI index is nearing 3,300, but not quite yet, commodities performance on the SGX plus a chock-a-block of reports coming out next week, including REITs.
|
|
|
19:22
|
JAN 20, 2022
20/01/22 - Market View, Australian Economy Outlook 2022On Market View, Claressa Monteiro is joined by Kyle Rodda, Analyst at IG, as they unpack the numbers and trends for the Australian economy in 2022 , with focus on ASX, property prices, trade spat with China, global supply chain disruptions as well as the upcoming CPI to be released next week.
|
|
|
16:13
|
JAN 20, 2022
20/01/22 - Chasing Cars : Hyundai TucsonOn Chasing Cars, Claressa Monteiro is joined by Julian Kho, Editor, SgCarMart, as they continue their review of the car of the week : this week, it’s the Hyundai Tucson, SgCarMart’s Most Improved winner.
|
|
|
19:42
|
JAN 19, 2022
19/01/22 - Soul of Business:On the Soul of Business, Claressa Monteiro speaks to Dr Jennifer Bourland, Head of Innovation Domain Cell & Tissue Systems, Evonik and Dr. Massimo Alberti, CEO and Founder, Revivo, on their partnership to develop organ-on-a-chip technology that will revolutionise chemical testing and drug development.
|
|
|
15:26
|
JAN 19, 2022
19/01/22 - Health Suites: Treating Covid-19On Health Suites, AstraZeneca has signed a new purchase agreement with the government of Singapore to deliver Evusheld, its long-acting antibody (LAAB) combination candidate, for the treatment of COVID-19. With the supply expected to arrive in Singapore by year end, Claressa Monteiro speaks to Vinod Narayanan, Country President, AstraZeneca Singapore, to find out more about Evusheld.
|
|
|
12:45
|
JAN 19, 2022
19/01/22 - Market View, SPACS on SGX, 19 JanThe buzz in 2022 is on Temasek’s Vertex Venture Holdings and Tikehau Capital SCA-backed Pegasus with both set to kick a first wave of SPAC listing on the Singapore Stock Exchange this week and next week. On Market View, Claressa Monteiro is joined by Emelia Tan, Research Analyst with the SGX as they deep dive into what is a SPAC company? Are there risks involved and if there are, are there any safeguards for investors?
|
|
|
15:08
|
JAN 18, 2022
18/01/22 - Health Suites: Lonely fruit flies aren’t so different from usOn Health Suites, Claressa Monteiro speaks to Professor Michael Young, 2017 Nobel Prize recipient for Physiology or Medicine. She learns more about his current research of fruit flies and the potential correlation to pathological consequences in humans.
|
|
|
17:44
|